Abstract: The invention relates to compositions comprising coenzyme Q10, methyl sulfonyl methane, citric acid, at least one polysorbate materials, and at least one water-soluble polysaccharide, and methods of administering nutritionally significant and/or therapeutically effective amounts of coenzyme Q10 in an oral formulation.